Pediatrics: Blood pressure target for renoprotection in children
Mak RH, Flynn J, Bakris G. Nat Rev Nephrol. 2010 Feb;6(2):67-8
This review summarizes results of the landmark ESCAPE trial, which has shown that lowering the blood pressure target to below the 50th percentile slows pediatric chronic kidney disease progression.
Related Articles:
- Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.
- Oral Phosphate Binders in Patients with Kidney Failure
- Bicarbonate Supplementation Slows Progression of CKD and Improves Nutritional Status
Recent Comments